Dr. Rohit Warrier

Dr. Rohit Warrier

Communications Director, American Diabetes Association, Senior Diabetes Specialist & physician, Apollo & Apotek Healthcare, Global Teaching faculty, American Board of Regenerative Medicine

Dr. Rohit Warrier, Senior Diabetes Specialist & physician, Apollo & Apotek Healthcare, Global Teaching faculty, American Board of Regenerative Medicine

Flag

Dr. Rohit Warrier is a dual board-certified physician specializing in Endocrinology and Regenerative Medicine, with over 15 years of clinical experience focused on diabetes remission, metabolic wellness, and patient-centered innovation. With a unique academic pathway integrating engineering principles into medicine, he brings a distinctive approach to understanding and managing metabolic disorders through precision-driven healthcare solutions. A physician-leader and physician-scientist in metabolism, endocrinology, and regenerative medicine, Dr. Warrier is committed to transforming healthcare through science, innovation, and digital health. He currently serves as the Medical Director at Twin Health India and is the Communications Director for the Immunology, Immunogenetics & Transplantation Special Interest Group of the American Diabetes Association (ADA). Dr. Warrier’s expertise includes diabetes remission, obesity and cardiometabolic risk reduction, regenerative medicine, digital therapeutics, and translational research. He strongly believes that metabolic disorders can undergo structured remission through precision lifestyle interventions and behavioral modifications integrated into daily routines. Passionate about advancing global healthcare standards, Dr. Warrier actively collaborates with healthcare leaders, researchers, and organizations to promote innovation in diabetes care, precision medicine, and regenerative healthcare through research, education, and clinical excellence.

Content will be updated soon.

Content will be updated soon.

Content will be updated soon.

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Upcoming Webinars

No upcoming webinars at the moment.

Past Webinars